Skip to main content
Premium Trial:

Request an Annual Quote

David Schwartz to Head NIEHS; Martin Madaus Leaves Roche Dx to Lead Millipore; CFO s of Accelrys, Third Wave to Step Down; Ali Arjomand of CombiMatrix Resurfaces at Accium BioSciences; and Others

David Schwartz will be the new director of the National Institute of Environmental Health Sciences and the National Toxicology Program, the NIH said on Monday. He will replace Kenneth Olden, who stepped down as NIEHS director last year, and will take up his appointment on April 4. Schwartz is currently the director of the pulmonary, allergy, and critical care division and vice chair of research in the department of medicine at Duke University. He holds an MD from the University of California San Diego, an MPH from Harvard School of Public Health, and a BA in biology from the Universityof Rochester.


 

Martin Madaus has been appointed as president and CEO of Millipore, effective no later than Feb.1, 2005, the Billerica, Mass.-based company said on Monday. He will replace Francis Lunger, who will remain chairman of the board during the transition. Madaus will also join Millipore's board of directors. He comes to Millipore from Roche Diagnostics, where he has been president and CEO in the USsince 2000. Madaus, who is originally from Hamburg, Germany, holds a PhD in veterinary medicine.


 

John Hanlon, CFO and executive vice president of Accelrys, will resign on Dec. 31 "to be closer to his family," according to an 8-K form that Accelrys filed with the US Securities and Exchange Commission this month. James Mihlik, the company's current worldwide controller, will become acting principal accounting officer while the company looks for a new CFO.


 

David Nuti will step down as CFO of Third Wave Technologies on Oct. 29, the Madison, Wis.-based company said today. He will be replaced by James Herrmann, who recently joined the company as vice president of finance. Most recently, Herrmann was a general partner in an electronics distribution company. He holds an MBA from the Universityof Chicagoand a bachelor's degree in accountancy from the University of Notre Dame. Nuti will help with the transition until the end of the year.


 

In addition, Kevin Conroy has been promoted to general counsel and secretary, from vice president of legal affairs. He replaces John Comerford, who will be leaving the company to pursue other interests after a transition period. Conroy has a law degree from the Universityof Michiganand a bachelor's degree in electrical engineering from Michigan State University.


 

Also, Slava Elagin has become vice president for research and development. He joined Third Wave last June as head of infectious disease research and development. Elagin holds a PhD from the Engelhard Institute of Molecular Biology, a master's degree from the Vavilov Institute of General Genetics, and a bachelor's degree from the Moscow Institute of Physics and Technology in Russia.


 

Ali Arjomand has joined Seattle-based Accium BioSciences, a startup focusing on measuring metabolites by mass spectrometry, as chief operating officer, GenomeWeb News has learned. He joins the company from CombiMatrix, where he was director of technical business development. Arjomand holds a doctorate from the University of California Davis.


 

Gregory Gosch has become vice president of marketing for Luminex, the Austin, Texas-based company said last week. Most recently, he was senior director for sales and marketing at Nanogen.


 

Bob Beltz has joined MFIC of Newton, Mass., as industry marketing manager of its microfluidics division, the company said earlier this month. In the past, he has held positions at Applied Biosystems, Schleicher & Schuell, and other companies. He also led his own consulting firm, Biotechnology Associates. Beltz holds a PhD in biochemistry.


 

Gary Noon has been appointed as senior vice president for pharmaceuticals of Diversa, effective in mid-November, the San Diego-based company said last week. He joins the company from IMS Health US, where he developed the USbusiness. Noon holds an MSc in molecular biology, a BSc in molecular sciences, and an MBA from WarwickUniversity in the UK.


 

Michael Schrader has left his post as co-CEO, COO, and CTO of German peptidomics company BioVision to take up a professorship for physical chemistry and instrumental analysis this month at the Universityof Applied Sciences Weihenstephan in Freising, Germany. He holds a PhD in physical chemistry from the Universityof Hanover.


 

Susan Davidson was named the inaugural George A. Weiss Professor of Computer and Information Science at the Universityof Pennsylvania. She co-developed the Kleisli data integration system at Penn, and was also the founding co-director of the PennCenterfor Bioinformatics from 1997-2000.


 

Elliott Sigal has been named acting president of the Bristol-Myers Squibb Pharmaceutical Research Institute, BMS said last week. He covers for James Palmer, the current president, who recently underwent surgery. Sigal is senior vice president for global clinical and pharmaceutical development at Bristol-Myers Squibb.


 

Manuel Hidalgo has joined the scientific advisory board of Aclara Biosciences, the Mountain View, Calif.-based company said today. He is an associate professor of oncology at the SidneyKimmelComprehensiveCancerCenterat Johns Hopkins University School of Medicine. Hidalgoholds an MD from the University Navarra Medical School in Pamplona, Spain, and a PhD in infectious diseases in cancer from the Universityof Autonoma in Madrid.


 

Myrna Francis was elected to the board of directors for Cedara Software, a medical software developer. Francis, who previously served as general manager of IBM Canada's Health and Life Sciences Industry Group, heads her own healthcare IT consulting practice.


 

Louis Kunkel has won this year's Allan Award from the American Society of Human Genetics. He is the director of the program in genomics at Children's Hospital Boston. Kunkel was honored for nearly two decades of work on the genetics of muscular dystrophy.


 

Alan Hollingsworth has joined the scientific advisory board of Power3 Medical of the Woodlands, Texas, the company said on Monday. He is the medical director of the Mercy Women's Center in Oklahoma City.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.